| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/19/2011 | CN101947290A Medicament with yin-nourishing effect |
| 01/19/2011 | CN101947280A Medicament for treating leg pain and leg numbness |
| 01/19/2011 | CN101947277A Chinese medicinal oral preparation for treating rheumatism, rheumatoid diseases and arthritis |
| 01/19/2011 | CN101947276A Chinese medicinal composition for treating rheumatic arthritis |
| 01/19/2011 | CN101947274A Detection method of traditional Chinese medicine composition with antibacterial and anti-inflammatory effects |
| 01/19/2011 | CN101947255A Magnoliabiloba extract and extracting method thereof |
| 01/19/2011 | CN101947244A Disinfection pill |
| 01/19/2011 | CN101947237A Externally-applied hypochlorous acid liquid with functions of oxidizing, disinfecting, expelling and removing toxins |
| 01/19/2011 | CN101947233A Compound medicinal composition for treating livestock and poultry respiratory disease and soluble powder thereof |
| 01/19/2011 | CN101947230A Application of 5'-AMP for treating urarthritis |
| 01/19/2011 | CN101947218A Method for modulating calcium ion-release-activated calcium ion channels |
| 01/19/2011 | CN101947215A Application of flavonoid compound in tangerine peel to preparation of medicament for inhibiting angiogenesis |
| 01/19/2011 | CN101947198A Toothpaste special for pregnant women and preparation process thereof |
| 01/19/2011 | CN101946986A Nanometer anion fabric seaman body-building working uniform with characteristics of ultra-oleophobic and ultra-hydrophilic properties, antifouling property and self-cleaning property |
| 01/19/2011 | CN101627986B Acedofenac-paracetamol pharmaceutical composite and liposome solid preparation thereof |
| 01/19/2011 | CN101560213B Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application |
| 01/19/2011 | CN101536997B Application of ginseng alkynol in pharmacy |
| 01/19/2011 | CN101450184B Plaster for treating rheumatism bone disease |
| 01/19/2011 | CN101415410B The use of bupropion metabolites for the treatment of inflammatory disorders |
| 01/19/2011 | CN101375849B Novel dosage form of sinomenine medicament or hydrochlorate thereof and preparation technique thereof |
| 01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
| 01/19/2011 | CN101296928B Compounds and compositions as protein kinase inhibitors |
| 01/19/2011 | CN101264275B Medicated pillow for treating scapulohumeral periarthritis and cervical spondylosis |
| 01/19/2011 | CN101254286B Chinese medicinal composition for curing wind dampness and rheumatoid |
| 01/19/2011 | CN101235070B Oleanane triterpene with A ring containing double bond and C ring containing conjugated ketenes, and use thereof |
| 01/19/2011 | CN101190277B Method for preparing stemmacantha uniflora blood circulation-activating, stasis-removing and wind-damp-expelling wine |
| 01/19/2011 | CN101160290B 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 01/19/2011 | CN101119716B External plaster containing flurbiprofen |
| 01/19/2011 | CN101092397B Structure modified compound of sinomenine, and prepartion method |
| 01/19/2011 | CN101052638B 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 01/18/2011 | US7872151 Inhibitors of α4 mediated cell adhesion |
| 01/18/2011 | US7872142 Coumarin derivatives useful as TNFα inhibitors |
| 01/18/2011 | US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 01/18/2011 | US7872129 Nitrogen compounds such as (6-(3-Methylaminopropyl)-2-(2-tri-fluoromethylphenyl)pyrimidin-4-yl)-(1H -pyrazolo(3,4-b)pyridin-3-yl)-amine, use as glycogen synthase kinase-3 (GSK-3) antagonists |
| 01/18/2011 | US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent |
| 01/18/2011 | US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer |
| 01/18/2011 | US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
| 01/18/2011 | US7872025 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 01/18/2011 | US7872017 such as 5-{5-[(endo)-8-methyl-8-aza-bicyclo[3.2.1]oct-3-yloxy]-pyridin-2-yl}-1H-indole, having nicotinic receptors modualtory activity, used for the treatment of attention deficit disorder, senile dementia, Down's syndrome, amyotrophic lateral sclerosis, Huntington's, Pick's and Alzheimer's disease |
| 01/18/2011 | US7872014 Anaplastic lymphoma kinase modulators and methods of use |
| 01/18/2011 | US7871984 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 01/18/2011 | US7871644 Mixture of drug, aminoacrylate polymer and acid |
| 01/18/2011 | US7871627 Gram positive bacteria preparations for the treatment of disease comprising an immune dysregulation |
| 01/18/2011 | CA2500225C Pyrazole compounds |
| 01/18/2011 | CA2491895C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/18/2011 | CA2477769C Ophthalmic composition comprising ascomycin |
| 01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 01/18/2011 | CA2416874C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/18/2011 | CA2372850C Synergistic combination comprising roflumilast and a pde-3 inhibitor |
| 01/18/2011 | CA2331460C Heterocyclic inhibitors of p38 |
| 01/18/2011 | CA2321881C Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 01/18/2011 | CA2320807C Method and composition for treatment of inflammatory conditions |
| 01/18/2011 | CA2269895C Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract |
| 01/14/2011 | CA2709589A1 Civamide patch for localized post-incisional neuropathic pain |
| 01/13/2011 | WO2011005832A1 Stable crystalline polymorphs of the dipotassium salt of (s) -2- {4- [2- (2, 4-diamin0-quinaz0lin-6-yl) -ethyl] -benzoylamino} -4-methylenξ-penta nedioic acid |
| 01/13/2011 | WO2011005295A1 Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto |
| 01/13/2011 | WO2011005290A1 Disubstituted oxadiazole derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 01/13/2011 | WO2011004847A1 NOVEL HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
| 01/13/2011 | WO2011004843A1 Pharmaceutical composition for treatment of sirs or highly pathogenic influenza infection |
| 01/13/2011 | WO2011004733A1 Activity enhancer for oxidized protein hydrolase |
| 01/13/2011 | WO2011004166A1 Combined preparation for use as a medicament |
| 01/13/2011 | WO2011003925A1 Humanised antibodies to toll-like receptor 2 and uses thereof |
| 01/13/2011 | WO2011003362A1 Salts of 13a-(s)desoxytylophorinine, preparation methods and pharmaceutical compositions and uses thereof |
| 01/13/2011 | WO2011003236A1 The preparation and uses of a longan seed extract |
| 01/13/2011 | WO2010115252A9 PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF-α MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES |
| 01/13/2011 | WO2010107807A3 Compounds for treating inflammation and pain |
| 01/13/2011 | WO2010102112A9 Treatment of drug-related side effect and tissue damage by targeting the cd24-hmgb1-siglec10 axis |
| 01/13/2011 | US20110009955 Compounds and method for coating surfaces in a hemocompatible manner |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009471 Oligonucleotide analogues and methods utilizing the same |
| 01/13/2011 | US20110009470 Nucleic acid external skin formulation |
| 01/13/2011 | US20110009465 3-phenoxymethylpyrrolidine compounds |
| 01/13/2011 | US20110009463 Geranylgeranyl transferase inhibitors and methods of making and using the same |
| 01/13/2011 | US20110009452 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 01/13/2011 | US20110009449 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/13/2011 | US20110009448 Compound |
| 01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
| 01/13/2011 | US20110009444 N-azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009439 Indene derivatives as pharmaceutical agents |
| 01/13/2011 | US20110009436 Novel therapeutic uses of adrenergic alpha-1 receptor antagonists |
| 01/13/2011 | US20110009434 Crystals of isopropyl ester of n-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl -1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2h)-yl]-l- phenylalanine hydrochloride, production method thereof and use thereof |
| 01/13/2011 | US20110009432 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof |
| 01/13/2011 | US20110009430 Methods and compositions for treating pain |
| 01/13/2011 | US20110009429 Heterocyclic compounds as inhibitors of cxcr2 |
| 01/13/2011 | US20110009426 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists |
| 01/13/2011 | US20110009422 1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition |
| 01/13/2011 | US20110009418 Therapeutic agents useful for treating pain |
| 01/13/2011 | US20110009417 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/13/2011 | US20110009415 Thienopyridazine Compounds, Their Preparations, Pharmaceutical Compositions And Uses |
| 01/13/2011 | US20110009413 Cyclic triazo and diazo sodium channel blockers |
| 01/13/2011 | US20110009410 Apoptosis signal-regulating kinase inhibitors |
| 01/13/2011 | US20110009409 Dual-acting pyrazole antihypertensive agents |
| 01/13/2011 | US20110009407 Pyridinone antagonists of alpha-4 integrins |
| 01/13/2011 | US20110009400 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009396 Tricyclic compounds for the treatment of inflammatory disorders |
| 01/13/2011 | US20110009393 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof |
| 01/13/2011 | US20110009386 Furo[3, 2-b] pyrr0l-3-0nes as cathespin s inhibitors |
| 01/13/2011 | US20110009385 Compounds |
| 01/13/2011 | US20110009382 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles |
| 01/13/2011 | US20110009377 Azetidine derivatives, their preparation and their application in therapy |